DatasetName,NUP93_S(165) NUP93_S(434) NUP93_S(647) NUP93_S(80),NUP93_S(364) NUP93_S(430) NUP93_S(438) NUP93_S(6) NUP93_S(66) NUP93_S(72) NUP93_S(75) NUP93_S(772) NUP93_S(82) NUP93_T(159) NUP93_T(51) NUP93_T(766),NUP93_S(112) NUP93_S(52) NUP93_S(764) NUP93_S(767) NUP93_T(49) NUP93_T(50)
RM2024_Intensity D4-1___3,,,
RB2022_4_PostEndurance,,,
FSO2013_Ratio M/L normalized Rep3,,,0.5758794556320975
SR2019_MCF7_Biol_repl_3,,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,,
SR2019_LM2_Biol_repl_1,,,
RCJD2014_15min_1,,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,,
CK2022_7 16-1,,,0.6090530211316297
NJH2025_Sub12_HIIT_Mid,,,
AH2018_LFQ_IT_1_C,,,
RKK2015_TNF-α/basal,,,
JJ2018_Ratio H/M normalized pP2,,,
NJH2025_Sub12_MICT_Pre,,,
NJH2025_Sub7_MICT_Post,,,
DL2023_control-3,,,
ZX2022_Control Replicate 2,,,0.5912266692097995
HS2024_6_B_T3,,0.5174754945955369,0.6070635092105738
JW2015_Intensity pre1,,0.4965949554831661,
IMM2018_normalised rep. int. Empty-3,,0.5245366284543264,
AMK2021_30R_p5,,,
FSO2013_Ratio M/L normalized Rep1,,0.5490504520754398,0.6108297501996316
SR2019_MDAMB231_Biol_repl_4,,,
GF2025_P2_Sph,,,0.6055844973473165
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,,
NJH2025_Sub13_HIIT_Mid,,,
CP2009_Ratio M/L,,,
NJH2025_Sub7_HIIT_Post,,,
KBE2022_Log2_Ex_44_T,,0.5309968654136924,0.6287848247839133
DB2022_Intensity L2,,,
TM2022_mock.4h.C,,,
AST2020_anti-CD3.2,,,0.5874585235302142
CW2012_10 µM Erl/control Experiment 1 Replicate B,,,
HS2024_7_B_N1,0.4093876316689229,0.5291919866842926,
FSO2013_Ratio M/L normalized Rep1___1,,0.5487445180600755,0.6106467276138473
SAS2015_AZD/DMSO_Exp3,,,
RM2024_Intensity D0-2___3,,,
RM2024_Intensity D6-1,,,
RB2022_8_RecoverySprint,,,
RB2022_5_PreEndurance,,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,,
EP2017_Untreated R#4 normalized log2 ratio,,0.5339081109472829,
WZ2023_Pu_010_30min,0.40115831607113384,0.5134170422678886,
AS2011_Ratio H/L Proteins RNAi_2,,,
RB2022_4_PreStrength,,,
NJH2024_Sub4_MICT_Post,,,
AH2018_LFQ_M_1_X,,,
RB2022_8_RecoveryEndurance,,,
KBE2022_Log2_Ex_14_U,,0.5328065206097493,0.6193544170698195
FSO2013_Ratio M/L normalized Rep3___3,,,
AH2018_TMTMS3_1_C,,,0.5702737043459363
JJ2018_Ratio H/L normalized___1,,,
ZQ2022_C2,,,
RB2022_5_PreSprint,,,
PG2020_Intensity 8h_C,,,0.6276862178117815
AH2018_SILAC_MR_2_N,,,
MV2014_Ratio M/L normalized A1___2 (2 min),,,
TM2022_S2.8h.B,,,
MV2014_Ratio M/H normalized B3___1 (30 min),,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,,
RM2024_Intensity D6-1___2,,,
NJH2025_Sub7_MICT_Mid,,,
LY2019_P1+,,,0.6044388157753677
AS2011_Ratio H/L Proteins Inhi_2,,,
BS2014_Log2(Ratio H/L normalized),,,
UK2020_HCM_2,,,
FSO2013_Ratio H/L normalized Rep2___2,,,
EP2017_Pervanadate R#3 normalized log2 ratio,,0.5235225180164871,
RM2024_Intensity D4-3___3,,,
RB2022_5_PreStrength,,,
NJH2024_Sub4_MICT_Mid,,,
TM2022_S2.4h.A,,,
RB2022_5_PostStrength,,,
GF2025_P6_Sph,,,0.5780537130059759
RB2022_2_PreSprint,,,
ZX2022_CB treated Replicate 3,,,0.5901541169153072
RM2024_Intensity D6-2___3,,,
WZ2023_Pe_025_10min,0.3862199704909238,0.5114970796510999,
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,,
AST2020_anti-CD3+PDL2.1,,,0.5872158716182514
KBE2022_Log2_Ex_34_U,,0.5314951147815713,0.6232558474860096
WZ2023_Pu_005_10min,0.38726453265882343,0.5124934164686314,
AS2011_Ratio H/L RNAi_2_1,,,
NJH2024_Sub9_HIIT_Mid,,,
CK2022_9 40-1,,0.5096936312886123,0.6319881865770055
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,,
LG2023_GSK3α-1_intensity,,0.5254927958748038,
WZ2023_Pu_025_30min,0.39791270885138164,0.5147752393990722,
AH2018_SILAC_MR_2_X,,,
HS2024_4_PD_T2,0.4150560938796451,0.5150303876494206,
NJH2024_Sub4_HIIT_Pre,,,
RB2022_2_RecoverySprint,,,
AS2011_Ratio H/L Protein RNAi_1,,,
RM2024_Intensity D2-1___2,,,
CR2017_Ratio Replicate 1.4,,0.5305369244321191,0.5994548063684663
FR2021_Norm.Intensity.B,,,
RM2024_Intensity D6-2___1,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,,0.6077642402308556
RB2022_5_PostSprint,,,
EJN2021_3_Rest_Basal,,,0.6078074656355332
CR2017_Ratio Replicate 1.3,,0.5297178991089262,0.5947003383508807
AS2011_Ratio H/L Normalized by Protein RNAi_2,,,
KTGR2014_Ratio-Rapa 7 mins,,,
AMK2021_120R_p1,,,
AH2018_SILAC_3_X,,,
JJ2018_Ratio M/L normalized pP3,,,
AH2018_SILAC_M_2_N,,,
HS2024_7_PD_T2,0.3571820569139908,0.5136566872130591,
FSO2013_Ratio H/L normalized Rep1___1,,,0.6130994432460507
AH2018_LFQ_1_C,,,
AS2011_Ratio H/L Normalized Inhi_1_3,,,
KBE2022_Log2_Ex_28_T,,,0.6222613610421335
HS2024_3_B_N1,,0.5233161248123404,
RM2024_Intensity D4-2___3,,,
WZ2023_Pe_025_30min,0.3951830217093822,0.5114545058626736,
CK2022_11 40-1,,0.5119599922560915,0.6307861819565388
CW2012_10 µM Erl/control Experiment 3 Replicate B,,,
AH2018_SILAC_2_X,,,
MV2014_Ratio H/M normalized A2___2 (2 min),,,
AS2011_Ratio H/L RNAi_1_2,,,
KS2014_Intensity E15_1,0.39129309570527665,,0.6075637390484616
FSO2013_Ratio H/L normalized Rep2,,,0.595846860490458
WZ2023_Pu_005_20min,0.399673764526278,0.513632170076375,
NJH2024_Sub10_MICT_Post,,,
RM2024_Intensity D2-3___1,,,
CR2017_Ratio Replicate 1.5,,0.530627487775,0.6096721745899294
CW2012_10 µM Gef/control Experiment 2 Replicate B,,,
HS2024_7_B_T3,0.4439876367801838,0.5172375149282799,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,,
AS2011_Ratio H/L RNAi_1,,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,,
AH2018_LFQ_M_1_C,,,
NJH2025_Sub7_MICT_Pre,,,
SR2019_SKBR3_Biol_repl_2,,,
HS2024_9_B_T2,,0.5098729105723323,0.5932867059119373
KTGR2014_Ratio-AA 7 mins,,,
MV2014_Ratio L/H normalized B3___3 (5 min),,,
HS2024_3_PD_T1,,0.5454449680009067,
FSO2013_Ratio M/L normalized Rep3___2,,,
SR2019_BT549_Biol_repl_3,,,
RCJD2014_20min_mean,,,
FR2021_Norm.Intensity.H,,,
RB2022_2_PreStrength,,,
DB2022_LFQ intensity L1.2,,,
HS2024_4_B_N1,0.41260272145343757,0.5178404047467596,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,,
CK2022_1 16-1,,,0.6081408194794745
CK2022_1 200-1,,0.5262781158552235,0.6205490673244526
PG2020_Intensity Mock_10h_D,,,0.6305502199866736
SR2019_MCF10A_Biol_repl_2,,,
JJ2018_Ratio M/L normalized pP2___2,,,
HS2024_6_PD_T1,,0.5007644946733956,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,,
RB2022_6_RecoveryEndurance,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,,
EP2017_Mitotic R#2 normalized log2 ratio,,0.5303801416337762,
RCJD2014_5min_1,,,
RM2024_Intensity D4-1___1,,,
DL2023_24h-1,0.42916982959513184,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,,
TM2022_S2.4h.C,,,
SAS2015_PLX/AZD_Exp2,,,
CR2017_Ratio Replicate 3.3,,0.5230296447046151,0.5654696940409277
PG2020_Intensity 2h_C,,,0.6004829462697318
VOI2024_Veh2 di,,,
ZX2022_CB treated Replicate 2,,,0.588055759366033
KBE2022_Log2_Ex_8_T,,0.5282261795275964,0.6149070103827153
NJH2025_Sub10_MICT_Post,,,
HS2024_6_I_T3,,0.5345855350822407,
RN2012_L11,,,
AS2011_Ratio H/L Normalized Inhi_2_2,,,
IMM2018_normalised rep. int. Empty-1,,0.5228969843154195,
HS2024_5_PD_T1,,0.5250778351974975,
AH2018_LFQ_M_2_C,,,
CK2022_3 40-1,,0.5069145324385035,0.6230293706159651
RBK2021_1260T Early,,,
NJH2024_Sub4_HIIT_Post,,,
HS2024_4_I_T1,0.4865297162796193,0.527819554063114,
YA2020_Reporter_intensity_Cancer_No.5,,,
HH2022_Reporter intensity 8,,,
ZQ2022_N2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,,
FSO2013_Ratio H/L normalized Rep3___3,,,
AH2018_TMTMS3_2_N,,0.5283046957430722,0.5938680932200939
EJN2021_5_Rest_Basal,,,0.6112998086365157
NJH2025_Sub2_HIIT_Post,,,
NJH2025_Sub1_MICT_Post,,,
HS2024_9_B_T1,,0.5108498276366104,0.6204919369270779
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,,
JAW2011_Ratio H/L LS2_1,,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,,
NJH2024_Sub6_HIIT_Pre,,,
AH2018_SILAC_3_N,,,
YA2020_Reporter_intensity_Normal_No.1,,,
HS2024_3_B_T1,,0.5459912618863744,
JJ2018_Ratio H/L normalized___2,,,
RM2024_Intensity D0-2,,,
MV2014_Ratio M/L normalized B1___2 (5 min),,,
RB2022_7_PostStrength,,,
RB2022_1_PostEndurance,,,
CR2017_Ratio Replicate 3,0.4249408957073674,,0.6010495398190735
SR2019_Hs578T_Biol_repl_3,,,
MV2014_Ratio L/H normalized B3___1 (5 min),,,
RBK2021_1244T Early,,,
RB2022_3_PostSprint,,,
NJH2024_Sub13_MICT_Mid,,,
KTGR2014_Ratio-AA 2 mins,,,
GF2025_P7_Sph,,,0.5593139683413549
HS2024_8_I_T3,,0.5330759946642151,
CF2017_EOC 3,,,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,,
HS2024_6_PD_T3,,0.5483577021139611,
DL2023_12h-2,,,
RM2024_Intensity D6-3___1,,,
FS2019_Ctr1,,,
WZ2023_Pu_010_20min,0.39511333903119283,0.5123398895240682,
AS2011_Ratio H/L_3,,,
CK2022_1 40-1,,0.506939395668938,0.6224843770276207
RNJ2017_Log2_ratio_Tsup:Trest_D1,,,
CK2022_8 16-1,,,0.6100248009305926
KS2014_Intensity N3,0.4294435192055358,0.5167959233023119,0.614105647428279
RB2022_4_RecoveryEndurance,,,
RB2022_5_RecoveryEndurance,,,
JAW2011_Ratio H/L LS1a_2,,,
NJH2024_Sub12_HIIT_Mid,,,
AH2018_LFQ_IT_1_N,,,
FSO2013_Ratio H/M normalized Rep2,,,0.592463881071867
RAM2015_Log2 A,,0.5682399483987371,0.5886070574897088
HS2024_8_PD_T1,,0.5278275526752493,
JJ2018_Ratio H/L normalized pP2,,,
CF2017_OSE 27,,,
KS2014_Intensity E15_2,,,
BS2014_Log2(Ratio H/L protein),,,
PG2020_Intensity 8h_A,,,0.6231220409204086
HS2024_7_I_T1,0.44408394260394163,0.4802276687308595,
VOI2024_Veh3 di,,,
RKK2015_TNF-α+SC-514/basal,,,
SR2019_JIMT1_Biol_repl_1,,,
HW2015_Ratio H/L normalized Exp2,,,
HS2024_3_I_N1,,0.5117009878362277,
AH2018_SILAC_M_3_X,,,
NJH2024_Sub9_HIIT_Post,,,
AS2011_Ratio H/L RNAi_1_3,,,
GRW2016_Ratio H/L normalized SILAC 1___2,,,
NJH2025_Sub1_HIIT_Pre,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,,0.6054165511887349
NJH2024_Sub4_HIIT_Mid,,,
VOI2024_0.1uM 2 h_1 di,,,
KBE2022_Log2_Ex_6_T,,,0.6142403701808742
RM2024_Intensity D4-3___1,,,
AH2018_LFQ_4_X,,,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,,
RB2022_8_PostEndurance,,,
NJH2025_Sub4_MICT_Mid,,,
YP2020_Intensity C30_R1_mult_log2,,,
AST2020_anti-CD3.1,,,0.5888970078150112
NJH2025_Sub4_HIIT_Post,,,
EP2017_Untreated R#4 log2 ratio,,0.5340270187146623,
HS2024_6_B_N1,,0.5326950024013711,
KBE2022_Log2_Ex_27_T,,0.5241858808177818,0.6164870512533613
CW2012_10 µM Gef/control Experiment 1 Replicate A,,,
VOI2024_0.1uM 24 h_1 mono,,,
AMK2021_120R_p5,,,
AS2011_Ratio H/L Proteins,,,
NJH2024_Sub7_HIIT_Post,,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,0.5276480042048237,
AS2011_Ratio H/L RNAi_2_2,,,
RB2022_7_RecoveryStrength,,,
AH2018_SILAC_IT_3_X,,,
JAW2011_Ratio H/L,,,
PG2020_Intensity 10h_C,,,0.6587476011219845
FSO2013_Ratio M/L normalized Rep2,,0.5021368129927998,0.6003262302433002
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,,
HH2022_Reporter intensity 5,0.40050805809858214,,
SR2019_HCC1954_Biol_repl_2,,,
CK2022_14 40-1,,0.5108892189524935,0.6317164845781934
RB2022_6_PreSprint,,,
NJH2025_Sub12_MICT_Mid,,,
PG2020_Intensity 4h_D,,,0.6501846500597601
NJH2025_Sub2_MICT_Post,,,
AH2018_LFQ_4_C,,,
DL2023_control-1,,,
AR2021_ALG 10 μM,,,0.593664225123454
JAW2011_Ratio H/L LS2_2,,,
AH2018_SILAC_IT_3_N,,,
EJN2021_4_Rest_Ins,,,
RN2012_H05,,,
NJH2024_Sub7_HIIT_Mid,,,
GF2025_P2_Adh,,,0.6158064169629429
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,,
RB2022_8_PostSprint,,,
EJN2021_1_Rest_Ins,,,
HH2022_Reporter intensity 3,0.4355780705873923,,0.6189595147279078
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,,
AH2018_SILAC_IT_1_C,,,
JW2021_After_3,,0.5265022668465136,0.602476959968942
GF2025_P8_Sph,,,0.5906139451366885
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,,
JJ2018_Ratio M/L normalized pP2___1,,,
AH2018_SILAC_2_N,,,
CK2022_11 200-1,,0.5368883377406389,0.6254164488063428
CK2022_12 200-1,,0.5391848941820095,0.6280801028855746
AS2011_Ratio H/L Normalized by Protein RNAi_1,,,
RM2024_Intensity D2-1___3,,,
NJH2024_Sub1_MICT_Pre,,,
HH2022_Reporter intensity 9,0.37669641428863343,,0.5900766770411134
WZ2023_Su_010_20min,0.3942806425785242,0.5136744159188226,
AH2018_TMTMS2_2_N,,0.5245568703743205,0.5741219802184028
NJH2024_Sub13_MICT_Pre,,,
KBE2022_Log2_Ex_41_U,,0.5303675588645792,0.6274255602914797
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,0.5323914962702169,
AH2018_TMTMS3_Pool,,0.5304236859222526,0.596917619554848
KS2014_Intensity N4,0.43799166802227363,0.5318776591481825,
NJH2024_Sub1_HIIT_Post,,,
MM2018_Ratio H/L replicate2,,,
RM2024_Intensity D4-2___2,,,
NJH2024_Sub13_HIIT_Pre,,,
CF2017_OSE 26,,,
CK2022_14 200-1,,0.5323895573446683,0.6264866080193967
SR2019_Hs578T_Biol_repl_1,,,
RB2022_7_PostSprint,,,
TM2022_mock.4h.A,,,
NJH2025_Sub12_HIIT_Pre,,,
AH2018_TMTMS3_1_N,,0.5334047650707575,0.5920689735807693
AST2020_anti-CD3+PDL2.2,,,0.5855864035309529
PG2020_Intensity Mock_10h_A,,,0.6075756430791738
JW2021_After_2,,0.5244122025855661,0.6085980575990405
NJH2024_Sub2_MICT_Post,,,
EJN2021_2_Rest_Ins,,,0.6112871115479004
SR2019_LM2_Biol_repl_4,,,
CP2009_Ratio H/M,,,
JAW2011_Ratio H/L HS,,,
CK2022_13 16-1,,,0.6164309459509043
GF2025_P1_Adh,,,0.5675584252309519
GF2025_P1_Sph,,,0.583629246490164
EJN2021_5_Ex_Basal,,,0.6062045544932773
HS2024_7_I_T3,0.40450779246651025,0.5319297334927328,
JJ2018_Ratio H/L normalized pP2___2,,,
WZ2023_Pe_010_10min,0.3930998339297167,0.5141303537969827,
CF2017_EOC 1,0.41289377064360744,,
CK2022_3 200-1,,0.524821760192742,0.6206123576350004
AH2018_LFQ_IT_3_C,,,
SR2019_Hs578T_Biol_repl_2,,,
NJH2024_Sub12_HIIT_Post,,,
JJ2018_Ratio H/L normalized pP1___2,,,
MV2014_Ratio H/L normalized A1___2 (10 min),,,
NJH2024_Sub10_MICT_Mid,,,
NJH2024_Sub13_MICT_Post,,,
BS2014_Log2(Ratio H/L normalized Rep_1),,,
RB2022_3_RecoverySprint,,,
NJH2025_Sub1_HIIT_Mid,,,
RCJD2014_20min_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,,
HS2024_6_PD_T2,,0.5412389295107897,
HS2024_5_B_T1,,0.5159483035465299,0.6083548622108151
CW2012_10 µM Gef/control Experiment 2 Replicate A,,,
DL2023_12h-3,0.3948901482518643,,
SR2019_MDAMB231_Biol_repl_2,,,
HS2024_3_B_T2,,0.5519253619098089,
RB2022_6_PreStrength,,,
CK2022_2 40-1,,0.5075101930606764,0.6233214374185762
RB2022_1_PostSprint,,,
CK2022_4 200-1,,0.5247326982385923,0.6216276180034406
JW2021_Before_2,,0.5400033847903631,0.5878227474570524
TM2022_S2.12h.A,,,
MV2014_Ratio L/M normalized B2___2 (30 min),,,
CK2022_5 16-1,,,0.6085756612347013
AR2021_ALG 1 μM,,,0.6002583337722749
HS2024_4_B_T1,0.45574306517311913,0.5300875665914493,
MV2014_Ratio M/H normalized A3___1 (10 min),,,
SR2019_BT549_Biol_repl_4,,,
EJN2021_1_Rest_Basal,,,0.5999970244978298
NJH2025_Sub8_MICT_Post,,,
RCJD2014_5min_3,,,
CR2017_Ratio Replicate 3.2,,0.5221545234571517,0.580257956717622
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,,
GF2025_P7_Adh,,,0.5762551608446683
CK2022_9 16-1,,,0.6150805832590188
NJH2024_Sub6_HIIT_Post,,,
AMK2021_30R_p3,,,
AS2011_Ratio H/L Normalized RNAi_2,,,
RM2024_Intensity D0-2___2,,,
KS2014_Intensity pY_N4,,,
CK2022_13 200-1,,0.5321588534493588,0.6261616074625515
AS2011_Ratio H/L Normalized_2,,,
PG2020_Intensity 6h_D,,,0.6438240555025722
CK2022_16 16-1,,,0.6177529400275372
FS2019_db/db3,,,
CK2022_15 40-1,,0.5101112490221092,0.6332060210142018
NJH2024_Sub9_MICT_Pre,,,
BS2014_Log2(Ratio H/L unmodified peptide),,,
WZ2023_Su_005_10min,0.39972666744424656,0.5124941035120891,
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,,
KBE2022_Log2_Ex_41_T,,0.5294829913247557,0.6257483974407666
AMK2021_Ctrl_p1,,,
AH2018_LFQ_IT_3_X,,,
HS2024_5_PD_T3,,0.5361317158752449,
AH2018_TMTMS3_3_X,,0.5315369652032227,0.5956875826024662
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,,
KBE2022_Log2_Ex_40_U,,0.5299948155863555,0.622649022789652
AH2018_LFQ_M_1_N,,,
KBE2022_Log2_Ex_27_U,,0.5236208946881283,0.6118384802893114
HW2015_Ratio M/L normalized Exp3,,,
RKK2015_TNF-α/IKKb(K44M),,,
AH2018_SILAC_M_1_N,,,
HW2015_Ratio M/L normalized Exp1,,,
RB2022_5_RecoveryStrength,,,
YP2020_Intensity P10_R1_mult_log2,,,
RB2022_7_PreStrength,,,
YA2020_Reporter_intensity_Normal_No.4,,,
NJH2025_Sub13_HIIT_Pre,,,
PG2020_Intensity CT_D,,,0.6309139086441135
NJH2025_Sub9_MICT_Post,,,
VOI2024_Veh1 mono,,,
CK2022_12 16-1,,,0.6171324469383598
RN2012_L13,,,
LG2023_Control-1_intensity,,,
RM2024_Intensity D6-3___2,,,
KBE2022_Log2_Ex_8_U,,0.5269512367621598,0.6157305330265157
SR2019_SKBR3_Biol_repl_3,,,
NJH2024_Sub1_MICT_Post,,,
HS2024_3_I_T2,,0.5474951030302023,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,,
RM2024_Intensity D0-3___3,,,
HS2024_6_I_T2,0.4012649204689912,0.4923301370709685,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,,
AS2011_Ratio H/L Protein Inhi_1,,,
FSO2013_Ratio H/M normalized Rep2___1,,,0.5969830103911163
GRW2016_Ratio M/L normalized SILAC 5a___2,,,
CK2022_10 40-1,,0.5109389882944025,0.6297552849899425
NJH2024_Sub12_HIIT_Pre,,,
NJH2024_Sub8_MICT_Pre,,,
RM2024_Intensity D0-1___1,,,
LY2019_P3+,,,0.62698917703728
HH2022_Reporter intensity 6,0.3863347778754151,,0.587642327682648
RB2022_2_RecoveryStrength,,,
KTGR2014_Ratio-AA 15 mins,,,
AS2011_Ratio H/L Normalized RNAi_2_2,,,
KS2014_Intensity pY_N3,,,
MV2014_Ratio H/L normalized B1___2 (30 min),,,
LY2019_P5-,,,0.5568833723359725
HW2015_Ratio M/L normalized Exp2,,,
SR2019_HCC1419_Biol_repl_1,,,
AH2018_TMTMS2_3_X,,0.5249884069080243,0.5726549666082178
GF2025_P3_Adh,,,0.5889930932537065
SR2019_JIMT1_Biol_repl_2,,,
AH2018_TMTMS2_1_C,,0.522948873399382,0.5743118135719151
RM2024_Intensity D0-1___2,,,
LY2019_P4+,,,0.5608808064733233
KBE2022_Log2_Ex_19_U,,0.5296749981069953,0.6217839877149698
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,,
RB2022_4_PostStrength,,,
LG2023_GSK3α-3_intensity,,0.5233225644297109,
YA2020_Reporter_intensity_Cancer_No.1,,,
AST2020_Control,,,0.5914971452473693
JAW2011_Ratio H/L LS1a,,,
RCJD2014_5min_mean,,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,,
NJH2025_Sub1_MICT_Mid,,,
TM2022_S2.12h.C,,,
NJH2025_Sub9_MICT_Mid,,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,,
AS2011_Ratio H/L Normalized Inhi_1_2,,,
FSO2013_Ratio M/L normalized Rep2___1,,0.5023178841713442,0.5996083067131605
LG2023_Control-2_intensity,,,
NJH2024_Sub8_HIIT_Pre,,,
KS2014_Intensity pY_N2,,,
RB2022_5_RecoverySprint,,,
RB2022_7_RecoverySprint,,,
YA2020_Reporter_intensity_Normal_No.3,,,
HS2024_8_B_T2,,0.5235306996284318,0.5934433060917604
AH2018_LFQ_1_X,,,
RM2024_Intensity D6-1___1,,,
RCJD2014_10min_2,,,
FR2021_Norm.Intensity.M,,,
RM2024_Intensity D0-3___1,,,
KS2014_Intensity N2,0.43514104445073715,0.5108151997353133,
HH2022_Reporter intensity 1,0.4390339871702117,,0.618860643823553
HH2022_Reporter intensity 2,0.43734883193209484,,0.6180754893673976
RM2024_Intensity D6-2___2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,,
RM2024_Intensity D2-3___2,,,
YA2020_Reporter_intensity_Normal_No.5,,,
SR2019_MCF7_Biol_repl_1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,,
HS2024_8_B_T1,0.3993884478563724,0.5467586078512948,
NJH2025_Sub6_HIIT_Pre,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,,
EP2017_Untreated R#2 log2 ratio,,0.5145394776557822,
SR2019_LM2_Biol_repl_3,,,
RB2022_4_RecoveryStrength,,,
CR2017_Ratio Replicate 2,,0.5210436921384917,0.5979793326383915
CW2012_10 µM Erl/control Experiment 2 Replicate A,,,
FSO2013_Ratio H/M normalized Rep3,,,0.5836148929999664
AR2021_KD 72h,,,0.538551164149844
MV2014_Ratio H/M normalized B2___3 (5 min),,,
KBE2022_Log2_Ex_18_U,,0.5278368148577077,0.6144430485101553
AS2011_Ratio H/L Inhi_1_1,,,
NJH2024_Sub8_MICT_Post,,,
AH2018_TMTMS3_3_C,,0.5285143986540969,0.6022173805250499
KBE2022_Log2_Ex_9_U,,0.538783171390884,0.652160466267251
AH2018_SILAC_M_3_N,,,
KBE2022_Log2_Ex_13_T,,0.5324360169039962,0.6304542386621632
RM2024_Intensity D0-3,,,
SR2019_SKBR3_Biol_repl_1,,,
PG2020_Intensity Mock_10h_C,,,0.6291516650887005
CF2017_OSE 29,,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,,
NJH2025_Sub1_HIIT_Post,,,
DL2023_24h-2,0.40705350175986726,,
HS2024_7_B_N2,0.4110523037380416,0.5098973657643283,
PG2020_Intensity 10h_A,,,0.6476628023515107
RN2012_L12,,,
MV2014_Ratio M/L normalized B1___3 (5 min),,,
NJH2024_Sub8_MICT_Mid,,,
AH2018_LFQ_IT_4_C,,,
SAS2015_PLX/AZD_Exp1,,,
FR2021_Norm.Intensity.A,,,
FSO2013_Ratio H/M normalized Rep1___1,,,0.5988450272754448
JW2015_Intensity cap2,,0.49548287652627615,
BS2014_Log2(Ratio H/L normalized Rep_2),,,
NJH2024_Sub6_MICT_Post,,,
CK2022_8 40-1,,0.5081239327151388,0.6245597733115805
RB2022_7_RecoveryEndurance,,,
NJH2025_Sub12_HIIT_Post,,,
EJN2021_4_Ex_Basal,,,0.6028965505860315
TM2022_S2.12h.B,,,
RN2012_L15,,0.5295432295241745,
KS2014_Intensity pY_PV3,,,
TM2022_S2.4h.B,,,
PG2020_Intensity 4h_A,,,0.6241527718276644
FSO2013_Ratio H/M normalized Rep2___2,,,
TM2022_mock.4h.B,,,
KBE2022_Log2_Ex_24_U,,0.5293035314414304,0.6248651472011039
NJH2025_Sub13_MICT_Mid,,,
KS2014_Intensity C3,0.39996808386650046,0.520663521666974,
RB2022_1_PreSprint,,,
HS2024_4_I_N1,,0.5152414595321096,0.6247597750208019
CK2022_7 200-1,,0.5247591562910369,0.6213746182629297
CK2022_5 200-1,,0.5243355425964924,0.6198315185249648
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,,
FSO2013_Ratio H/L normalized Rep2___1,,,0.5964097281884463
NJH2024_Sub10_HIIT_Mid,,,
RB2022_2_PostEndurance,,,
AH2018_LFQ_2_C,,,
AH2018_SILAC_MR_1_X,,,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,,
IMM2018_normalised rep. int. Empty-2,,0.5232951971280353,
RM2024_Intensity D4-1,,,
KBE2022_Log2_Ex_25_U,,0.5293954391096042,0.6246024904163643
AH2018_SILAC_3_C,,,
EJN2021_5_Rest_Ins,,,
VOI2024_0.1uM 24 h_3 di,,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,,
DB2022_LFQ intensity L2.1,,,
FSO2013_Ratio H/M normalized Rep1,,,0.595922500008389
CK2022_4 16-1,,,0.6075944483654263
AS2011_Ratio H/L,,,
SR2019_MCF7_Biol_repl_4,,,
EJN2021_2_Ex_Ins,,,0.6074683386462307
AS2011_Ratio H/L Inhi_2_3,,,
JAW2011_Ratio H/L LS1a_1,,,
AH2018_LFQ_1_N,,,
SAS2015_PLX/DMSO_Exp1,,,
SFR2015_HL_log2_ratio_avg_c,,,
JJ2018_Ratio M/L normalized pP2,,,
NJH2024_Sub7_MICT_Mid,,,
PG2020_Intensity 6h_B,,,0.6106870022682377
FSO2013_Ratio H/L normalized Rep3,,,0.5782858118665195
GRW2016_Ratio H/L normalized SILAC 2___2,,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,,
JJ2018_Ratio M/L normalized,,,
KTGR2014_Ratio-AA 30 mins,,,
JW2021_After_1,,0.5463229492616252,0.609394975622415
NJH2025_Sub2_MICT_Mid,,,
HS2024_6_B_N2,,0.5348988492507711,
KBE2022_Log2_Ex_9_T,,0.5349902040721751,0.6496447679845891
AH2018_SILAC_IT_2_N,,,
AH2018_SILAC_IT_1_X,,,
HW2015_Ratio H/L normalized Exp3,,,
HS2024_7_PD_T1,0.3735082313683932,0.5401312473403866,
UK2020_UA_2,,,
RM2024_Intensity D2-1___1,,,
GF2025_P10_Sph,,,0.5749064851544481
WZ2023_Pe_025_20min,0.38962615830540714,0.5106821754395859,
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,,
AH2018_LFQ_2_N,,,
HS2024_4_I_N2,,0.5304075986672205,0.626546128863593
AH2018_TMTMS2_3_N,,0.5233221243275755,0.5755953471622851
RN2012_H06,,0.5323387297288419,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,,
HS2024_4_PD_T3,0.4196010866628737,0.5145119267265909,
WZ2023_Su_005_30min,0.39445647499847103,0.5149511968189292,
SR2019_HCC1419_Biol_repl_4,,,
JJ2018_Ratio H/M normalized___2,,,
SR2019_JIMT1_Biol_repl_3,,,
AS2011_Ratio H/L Protein,,,
UK2020_HCM_3,,,
NJH2024_Sub10_HIIT_Post,,,
CR2017_Ratio Replicate 3.1,0.46657843312691666,,0.6214153760059259
WZ2023_Su_025_10min,0.3923507461398128,0.5137535036852077,
AH2018_LFQ_IT_4_X,,,
CP2009_Ratio H/L,,,
VOI2024_0.1uM 24 h_3 mono,,,
RB2022_4_RecoverySprint,,,
RM2024_Intensity D6-3,,,
WZ2023_Su_005_20min,0.3998613504523601,0.5140158403947275,
CW2012_10 µM Gef/control Experiment 1 Replicate B,,,
SFR2015_HL_log2_ratio_avg_a,,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,,
RB2022_1_PreEndurance,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,,
LG2023_GSK3α-2_intensity,,0.525839427531266,
EP2017_Pervanadate R#1 log2 ratio,,0.5388101640457454,
NJH2025_Sub6_HIIT_Post,,,
RB2022_6_RecoverySprint,,,
KS2014_Intensity,0.44054281450266447,0.5327386381995187,0.6000498083113788
MV2014_Ratio H/M normalized A2___1 (2 min),,,
PG2020_Intensity 8h_D,,,0.6228066243782789
LY2019_P7+,,,0.5758883136402954
EP2017_Untreated R#1 normalized log2 ratio,,0.5376260620024677,
RN2012_L10,,,0.577445614198183
PG2020_Intensity 4h_C,,,0.6206443274587944
EP2017_Mitotic R#3 normalized log2 ratio,,0.5319390261303253,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,,
DB2022_LFQ intensity L1,,,
KBE2022_Log2_Ex_24_T,,0.5281902853944755,0.6230811501746149
RB2022_8_PostStrength,,,
AH2018_SILAC_IT_2_X,,,
HS2024_4_B_T3,0.46665170992765903,0.5347065269701171,
NJH2024_Sub2_HIIT_Post,,,
HS2024_8_B_N2,,0.5351588249425795,
NJH2025_Sub8_HIIT_Pre,,,
JJ2018_Ratio H/L normalized pP2___1,,,
HS2024_8_I_T2,,0.5332806764229702,
KBE2022_Log2_Ex_6_U,,,0.6084879312859258
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,,
CR2017_Ratio Replicate 1.1,0.42010902182874915,0.5183519962616747,0.5905174631140325
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,,
MV2014_Ratio M/H normalized B3___2 (30 min),,,
CK2022_16 200-1,,0.531722412462296,0.628161245290399
VOI2024_0.1uM 2 h_3 di,,,
EP2017_Mitotic R#1 normalized log2 ratio,,0.5259086208635748,
GF2025_P9_Sph,,,0.6087810292516198
CK2022_6 200-1,,0.5239559841241372,0.6192150386903909
NJH2024_Sub7_MICT_Post,,,
AH2018_TMTMS3_2_X,,0.5297017620544693,0.5962283239498309
NJH2024_Sub8_HIIT_Post,,,
DB2022_LFQ intensity R1,,,
JW2015_Intensity cap3,,0.5004496840669725,
SR2019_HCC1954_Biol_repl_1,,,
HS2024_4_I_T2,0.4377404731199135,0.5360835541407881,
NJH2024_Sub2_MICT_Mid,,,
VOI2024_0.1uM 2 h_2 mono,,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,,
HS2024_4_PD_T1,0.4112057283659162,0.4950597688677352,
SAS2015_AZD/DMSO_Exp1,,,
NJH2024_Sub1_MICT_Mid,,,
IMM2018_normalised rep. int. CDK5L-3,,0.522982295933003,
HS2024_3_B_T3,0.42526891482100876,0.5299082008587802,
MV2014_Ratio L/H normalized A3___2 (2 min),,,
NJH2025_Sub13_MICT_Pre,,,
SR2019_MDAMB231_Biol_repl_3,,,
GRW2016_Ratio H/L normalized SILAC 4___1,,,
MM2018_Ratio H/L replicate1,,,
PG2020_Intensity 2h_D,,,0.6331510817694727
EP2017_Untreated R#3 normalized log2 ratio,,0.5067472599473367,
MV2014_Ratio M/H normalized A3___3 (10 min),,,
NJH2024_Sub7_HIIT_Pre,,,
JAW2011_Ratio H/L LS2,,,
CK2022_8 200-1,,0.5255206931349675,0.6215688125642188
KS2014_Intensity pY_C4,,,
CR2017_Ratio Replicate 3.5,,0.5257614759066752,0.5882314614174532
RB2022_7_PostEndurance,,,
NJH2025_Sub4_HIIT_Pre,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,,
TM2022_mock.12h.A,,,
JJ2018_Ratio H/L normalized pP1,,,
EP2017_Pervanadate R#2 normalized log2 ratio,,0.5190890564335565,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,,
KS2014_Intensity pY_E5_4,,,
RM2024_Intensity D4-3___2,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,,
AH2018_SILAC_2_C,,,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,,
HS2024_7_I_N1,0.37537095326822906,0.5014604053530641,
KBE2022_Log2_Ex_29_T,,0.5319330408987075,0.630762959015423
HS2024_7_I_T2,0.3768456980910878,0.5336786342856294,
AS2011_Ratio H/L Normalized RNAi_2_3,,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,,
HS2024_6_B_T2,,0.5239389802642703,0.6045411181534865
AMK2021_45I_p5,,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,,
SAS2015_PLX/DMSO_Exp2,,,
EJN2021_1_Ex_Basal,,,0.6051253499604557
FR2021_Intensity.M,,,
RB2022_2_PostSprint,,,
AH2018_SILAC_MR_3_N,,,
MV2014_Ratio H/L normalized B1___3 (30 min),,,
CF2017_FTE 13,,,
PG2020_Intensity CT_C,,,0.6190555771023457
ZCP2016_Ratio H/L Rep 1,,,
FS2019_db/db2,,,
KS2014_Intensity pY_PV4,,,
KBE2022_Log2_Ex_39_U,,,0.6214055935539365
EP2017_Untreated R#3 log2 ratio,,0.5071806867557772,
RB2022_2_PostStrength,,,
AS2011_Ratio H/L Normalized_1,,,
MV2014_Ratio M/H normalized A3___2 (10 min),,,
CR2017_Ratio Replicate 3.4,,0.5252325744443803,0.5838883255328567
HS2024_8_PD_T2,,0.5217376619122654,
FS2019_Ctr2,,,
RB2022_6_PreEndurance,,,
FR2021_Norm.Intensity.G,,,
NJH2025_Sub9_HIIT_Post,,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,,
RM2024_Intensity D4-3,,,
HS2024_8_B_N1,,0.5378640655100674,
NJH2025_Sub10_MICT_Mid,,,
KBE2022_Log2_Ex_15_U,,,0.62453081139283
AS2011_Ratio H/L Normalized Inhi_2,,,
RKK2015_TNF-α/SC-514,,,
RB2022_3_PreSprint,,,
CR2017_Ratio Replicate 2.3,,0.5214355881450401,0.5713136833964756
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,,
GF2025_P4_Adh,,,0.6033455755864173
YA2020_Reporter_intensity_Normal_No.2,,,
YP2020_Intensity P30_R2_mult_log2,,,
NJH2025_Sub13_MICT_Post,,,
HS2024_4_B_N2,0.407309461690944,0.495402999440864,
HS2024_3_PD_T3,,0.5329353218731016,
AMK2021_120R_p3,,,
MV2014_Ratio L/H normalized A3___3 (2 min),,,
NJH2025_Sub10_HIIT_Pre,,,
FR2021_Intensity.G,,,
RAM2015_Log2 C,,0.5607827712857641,
AS2011_Ratio H/L Proteins Inhi_1,,,
FSO2013_Ratio H/M normalized Rep1___3,,,
AH2018_LFQ_M_2_N,,,
MV2014_Ratio M/L normalized A1___3 (2 min),,,
KBE2022_Log2_Ex_40_T,,0.5290678652774314,0.6252457892172957
CK2022_2 16-1,,,0.6092737442461188
RAM2015_Log2 B,,0.5696494725916733,0.5808785998730058
YP2020_Intensity C10_R1_mult_log2,,,
FSO2013_Ratio M/L normalized Rep1___2,,,
NJH2025_Sub8_MICT_Pre,,,
EJN2021_4_Rest_Basal,,,0.6089714325467795
YB2013_Ratio_H_L_Normalized_in_experiment_2,,,
JJ2018_Ratio H/M normalized pP3___1,,,
VOI2024_Veh2 mono,,,
HS2024_6_B_T1,,0.5178714045368006,0.6088422825112854
UK2020_HCM_5,,,
NJH2025_Sub10_HIIT_Post,,,
VOI2024_0.1uM 2 h_3 mono,,,
JW2015_Intensity pre3,,,
AS2011_Ratio H/L Normalized Inhi_2_1,,,
DL2023_24h-3,,,
HS2024_7_PD_T3,0.4001927797763815,0.5127797099173753,
PG2020_Intensity Mock_10h_B,,,0.6082349932448375
WZ2023_Su_025_30min,0.3898432315831841,0.5128568718088686,
AH2018_LFQ_4_N,,,
CR2017_Ratio Replicate 1.2,,0.517474516320717,0.588401533002148
AS2011_Ratio H/L Normalized by Proteins,,,
RB2022_6_RecoveryStrength,,,
HS2024_8_I_N1,,0.5459398485444892,
AMK2021_Ctrl_p3,,,
AS2011_Ratio H/L Protein Inhi_2,,,
HH2022_Reporter intensity 7,0.3689533923270395,,0.5933870367769094
AH2018_SILAC_M_1_X,,,
RB2022_7_PreEndurance,,,
VOI2024_0.1uM 24 h_2 di,,,
DL2023_control-2,,,
LY2019_P6+,,,0.545829599843708
DB2022_LFQ intensity R2,,,
GF2025_P6_Adh,,,0.6171161157931904
VOI2024_Veh1 di,,,
AS2011_Ratio H/L RNAi_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,,
VOI2024_Veh3 mono,,,
HS2024_5_I_T2,,0.5233502134512811,
NJH2025_Sub7_HIIT_Mid,,,
MV2014_Ratio H/L normalized B1___1 (30 min),,,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,,
RB2022_6_PostSprint,,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,,
AS2011_Ratio H/L Inhi_1,,,
AS2011_Ratio H/L Normalized RNAi_1_2,,,
AH2018_TMTMS3_2_C,,0.5331262980904975,0.5947641137910177
SR2019_Hs578T_Biol_repl_4,,,
RB2022_8_PreStrength,,,
KS2014_Intensity C5,,0.5262382140568412,
RM2024_Intensity D0-1,,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,,
YP2020_Intensity P30_R1_mult_log2,,,
NJH2025_Sub2_HIIT_Pre,,,
RB2022_3_RecoveryEndurance,,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,,
GF2025_P9_Adh,,,0.6353017015717054
RB2022_3_PostStrength,,,
TM2022_S2.8h.A,,,
AS2011_Ratio H/L RNAi_1_1,,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,,
NJH2025_Sub2_MICT_Pre,,,
MV2014_Ratio L/M normalized A2___3 (10 min),,,
MV2014_Ratio H/M normalized A2___3 (2 min),,,
HS2024_4_B_T2,0.4782023745402431,0.5161664401659593,
SR2019_BT549_Biol_repl_1,,,
AH2018_LFQ_M_4_N,,,
NJH2024_Sub8_HIIT_Mid,,,
PG2020_Intensity 8h_B,,,0.6271071310786743
AH2018_LFQ_2_X,,,
PG2020_Intensity 2h_B,,,0.6258293942310867
AS2011_Ratio H/L Proteins RNAi_1,,,
RB2022_4_PostSprint,,,
KS2014_Intensity E15_3,0.3925082717108233,0.5133584686065475,
GF2025_P3_Sph,,,0.5861039046271145
DB2022_LFQ intensity L2,,,
MV2014_Ratio H/L normalized A1___1 (10 min),,,
AH2018_SILAC_1_C,,,
NJH2024_Sub1_HIIT_Pre,,,
FSO2013_Ratio M/L normalized Rep2___2,,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,,
AS2011_Ratio H/L RNAi_2_3,,,
AH2018_SILAC_IT_1_N,,,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,,
RB2022_4_PreEndurance,,,
JJ2018_Ratio M/L normalized pP1,,,
CR2017_Ratio Replicate 2.4,,0.5260202606572996,0.5931239691415003
ZQ2022_N1,,,
LY2019_P6-,,,0.5596433481203021
RM2024_Intensity D2-3,,,
UK2020_HCM_1,,,
JW2015_Intensity pre2,,0.4931760650214662,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,,
RM2024_Intensity D2-1,,,
NJH2025_Sub12_MICT_Post,,,
MV2014_Ratio H/M normalized B2___2 (5 min),,,
RN2012_L14,,0.5381461465005141,
AH2018_LFQ_3_N,,,
RKK2015_TNF-α/IKKb,,,
SFR2015_HL_log2_ratio_std_b,,,
UK2020_UA_1,,,
KBE2022_Log2_Ex_13_U,,0.5293874531618146,0.6206112525283406
AS2011_Ratio H/L Normalized Inhi_1,,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,,
RB2022_1_RecoverySprint,,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,,
JJ2018_Ratio H/L normalized pP3,,,
CK2022_7 40-1,,0.5091467684849659,0.624087036617783
AS2011_Ratio H/L Inhi_1_3,,,
NJH2025_Sub10_HIIT_Mid,,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,,
JAW2011_Ratio H/L LS1b_1,,,
PG2020_Intensity 4h_B,,,0.6280594413498412
SR2019_BT549_Biol_repl_2,,,
RM2024_Intensity D4-2,,,
DB2022_LFQ intensity R2.2,,,
JJ2018_Ratio H/L normalized,,,
RB2022_5_PostEndurance,,,
HS2024_5_PD_T2,,0.4956501798247001,
WZ2023_Su_025_20min,0.40031995837112055,0.5143020032987592,
RM2024_Intensity D2-2___1,,,
IMM2018_normalised rep. int. CDK5L-2,,0.521991548315735,
LY2019_P8-,,,0.6562587233515462
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,,
FSO2013_Ratio H/L normalized Rep1,,,0.6095508413853711
NJH2024_Sub2_HIIT_Pre,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,,
CK2022_13 40-1,,0.5109694532611557,0.6319264137684661
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,,
RN2012_H02,,,0.5969284858632738
PG2020_Intensity 10h_D,,,0.6388874173506242
RB2022_8_PreEndurance,,,
HS2024_3_B_N2,,0.5206341405048333,
EJN2021_4_Ex_Ins,,,0.6046150028080834
AS2011_Ratio H/L Normalized by Protein,,,
EJN2021_1_Ex_Ins,,,0.6047938134636931
EP2017_Pervanadate R#3 log2 ratio,,0.5250589373184565,
FSO2013_Ratio M/L normalized Rep1___3,,,
NJH2025_Sub4_HIIT_Mid,,,
RCJD2014_5min_2,,,
RB2022_6_PostStrength,,,
AH2018_SILAC_MR_3_C,,,
AH2018_LFQ_M_4_C,,,
NJH2024_Sub4_MICT_Pre,,,
AS2011_Ratio H/L Normalized Inhi_1_1,,,
DL2023_12h-1,,,
MV2014_Ratio L/M normalized B2___1 (30 min),,,
DB2022_LFQ intensity L1.1,,,
NJH2025_Sub6_MICT_Pre,,,
NJH2025_Sub6_MICT_Post,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,,
RN2012_H04,,,
CK2022_6 40-1,,0.5072678768009468,0.6235622673341484
DB2022_LFQ intensity R2.1,,,
KBE2022_Log2_Ex_42_U,,,0.6394955517728836
LY2019_P3-,,,0.6213005095989743
FR2021_Intensity.A,,,
EJN2021_3_Ex_Ins,,,0.6043784055250346
MV2014_Ratio M/L normalized A1___1 (2 min),,,
WZ2023_Pe_005_30min,0.3921072395135573,0.5148462280296708,
HS2024_8_PD_T3,,0.5282241517764145,
EJN2021_3_Ex_Basal,,,0.6055122933374929
AST2020_Control.1,,,0.5910931050608287
JW2015_Intensity cap1,,0.5021676290933312,
PG2020_Intensity CT_A,,,0.6036146281975033
FS2019_Ctr3,,,
WZ2023_Pu_025_20min,0.40400238369402997,0.5144504663357323,
NJH2025_Sub4_MICT_Post,,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,,
GF2025_P10_Adh,,,0.5820216966079829
RB2022_1_RecoveryStrength,,,
SR2019_HCC1954_Biol_repl_4,,,
FR2021_Norm.Intensity.N,,,
HS2024_5_B_N1,,0.5184545905178464,
FSO2013_Ratio H/M normalized Rep3___3,,,
AH2018_TMTMS2_2_C,,0.5235434112840671,0.5711847608020336
RB2022_4_PreSprint,,,
DB2022_Intensity R2,,,
AH2018_TMTMS2_Pool,,0.5312489518010645,0.5981549439262127
HS2024_8_I_N2,,0.5249028200357643,
RB2022_3_RecoveryStrength,,,
NJH2024_Sub6_HIIT_Mid,,,
AH2018_SILAC_M_1_C,,,
LY2019_P8+,,,0.6390765621787936
RB2022_2_RecoveryEndurance,,,
JJ2018_Ratio H/M normalized pP2___1,,,
JAW2011_Ratio H/L HS_1,,,
RB2022_3_PostEndurance,,,
KS2014_Intensity pY_PV1,,,
JAW2011_Ratio H/L LS1b_2,,,
SR2019_MCF7_Biol_repl_2,,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,0.5200674975796477,
AS2011_Ratio H/L Normalized RNAi_1_1,,,
AH2018_LFQ_M_4_X,,,
NJH2024_Sub6_MICT_Pre,,,
JJ2018_Ratio M/L normalized pP1___2,,,
YP2020_Intensity C30_R2_mult_log2,,,
NJH2024_Sub9_HIIT_Pre,,,
AS2011_Ratio H/L Normalized Inhi_2_3,,,
RM2024_Intensity D0-1___3,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,,
KBE2022_Log2_Ex_28_U,,,0.6256871702549883
GRW2016_Ratio H/L normalized SILAC 1___1,,,
CF2017_FTE 17,,,
LY2019_P2-,,,0.5560777554472102
AH2018_LFQ_IT_1_X,,,
JJ2018_Ratio H/L normalized pP3___1,,,
RB2022_8_RecoveryStrength,,,
WZ2023_Pe_005_20min,0.3951813616694617,0.5148084904339082,
AST2020_Control.2,,,0.5912462657621035
NJH2025_Sub6_MICT_Mid,,,
RCJD2014_10min_1,,,
FSO2013_Ratio H/L normalized Rep2___3,,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,,
HS2024_3_I_T1,,0.5419468510353763,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,,
CK2022_4 40-1,,0.5070602422346283,0.621988788063001
SR2019_MCF10A_Biol_repl_4,,,
KS2014_Intensity pY_C5,,,
NJH2025_Sub4_MICT_Pre,,,
NJH2024_Sub9_MICT_Post,,,
CF2017_OSE 28,,,
HS2024_5_B_T2,,0.5476823145578086,0.628798678442298
HS2024_6_I_T1,0.389474823207694,0.5392844914710435,
HS2024_5_B_T3,,0.5217680084430172,
JJ2018_Ratio H/M normalized pP1___1,,,
KBE2022_Log2_Ex_36_U,,0.5261749931833268,0.6071480067431142
AH2018_TMTMS3_3_N,,0.5289237544098109,0.5968359896056087
SR2019_HCC1419_Biol_repl_2,,,
FR2021_Intensity.N,,,
AS2011_Ratio H/L Inhi_2_1,,,
AH2018_SILAC_MR_1_C,,,
NJH2024_Sub1_HIIT_Mid,,,
NJH2025_Sub8_HIIT_Mid,,,
EP2017_Mitotic R#3 log2 ratio,,0.5333684754867224,
KBE2022_Log2_Ex_36_T,,0.5260746517946108,0.6164223338628139
NJH2025_Sub6_HIIT_Mid,,,
WZ2023_Pu_005_30min,0.3891235204514819,0.5128264622341152,
KS2014_Intensity C2,0.39422443218276826,0.5244551819312141,
FSO2013_Ratio H/L normalized Rep1___2,,,
RM2024_Intensity D2-2,,,
KBE2022_Log2_Ex_42_T,,,0.6299958209660782
CK2022_9 200-1,,0.5369833458983825,0.6252973920577732
GRW2016_Ratio H/L normalized SILAC 2___1,,,
JJ2018_Ratio H/M normalized pP3___2,,,
DB2022_LFQ intensity R1.1,,,
CK2022_10 200-1,,0.5355651266743463,0.6237630163930996
NJH2024_Sub9_MICT_Mid,,,
JAW2011_Ratio H/L_2,,,
HS2024_7_I_N2,,0.5119802272127852,0.5997047134749925
RBK2021_1332T Late,,,
LY2019_P1-,,,0.61998024124568
RKK2015_TNF-α/basal.1,,,
RKK2015_TNF-α/TNF-α+SC-514,,,
CR2017_Ratio Replicate 2.5,,0.5253702312538415,0.5795764335936643
HS2024_3_I_T3,,0.5413563250555942,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,,
AS2011_Ratio H/L Normalized RNAi_1,,,
KS2014_Intensity E15_4,,0.5260585812700983,
ZQ2022_C3,,,
EJN2021_3_Rest_Ins,,,
YP2020_Intensity P10_R2_mult_log2,,,
MV2014_Ratio H/L normalized A1___3 (10 min),,,
NJH2025_Sub1_MICT_Pre,,,
KBE2022_Log2_Ex_39_T,,,0.6160128431120375
FSO2013_Ratio H/M normalized Rep3___2,,,
RM2024_Intensity D6-2,,,
EP2017_Untreated R#1 log2 ratio,,0.5380234227278821,
RKK2015_SC-514/basal,,,
RM2024_Intensity D6-1___3,,,
WZ2023_Pu_010_10min,0.39843068877162946,0.5138664980794397,
NJH2025_Sub9_HIIT_Mid,,,
SR2019_SKBR3_Biol_repl_4,,,
HS2024_5_I_T3,,0.5228042644279348,
KS2014_Intensity N1,0.42842532626812563,0.5312895479109417,
NJH2024_Sub12_MICT_Post,,,
TM2022_S2.8h.C,,,
CR2017_Ratio Replicate 1,0.43908901949125334,0.5210777214690795,0.6099160778940006
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,,
JJ2018_Ratio H/M normalized pP3,,,
AH2018_SILAC_MR_2_C,,,
LATM2013_Log2 Ratio (Medium/Light) Forward,,,
PG2020_Intensity 2h_A,,,0.6140525821909929
NJH2024_Sub6_MICT_Mid,,,
NJH2025_Sub13_HIIT_Post,,,
AH2018_SILAC_MR_3_X,,,
JJ2018_Ratio H/M normalized___1,,,
RCJD2014_15min_2,,,
AS2011_Ratio H/L_2,,,
AS2011_Ratio H/L Normalized,,,
RN2012_H03,,,
HS2024_5_B_N2,,0.5354341570208928,
HS2024_5_I_N1,,0.5192085835608283,
HS2024_6_I_N1,,0.5011065687100522,
AR2021_KD 48h,,,0.5885815064124601
FR2021_Intensity.B,,,
RB2022_3_PreEndurance,,,
HS2024_5_I_T1,,0.531063836134246,
NJH2024_Sub10_MICT_Pre,,,
SR2019_LM2_Biol_repl_2,,,
AST2020_anti-CD3,,,0.5917073318795961
SR2019_MDAMB231_Biol_repl_1,,,
RM2024_Intensity D2-3___3,,,
WZ2023_Pe_005_10min,0.39418996627691394,0.5145656525346923,
KBE2022_Log2_Ex_29_U,,0.5316295199531218,0.6244078450000442
HS2024_7_B_T1,0.4516577247844755,0.5146677601497105,
AH2018_LFQ_M_2_X,,,
AH2018_LFQ_IT_4_N,,,
CK2022_15 200-1,,0.5322179450482841,0.6274382000755928
RM2024_Intensity D4-1___2,,,
JJ2018_Ratio H/M normalized,,,
JJ2018_Ratio M/L normalized pP3___1,,,
KBE2022_Log2_Ex_34_T,,0.5309526538307879,0.6261307882782228
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,,
LY2019_P2+,,,0.5699540406489726
LATM2013_Log2 Ratio (Light/Medium) Reverse,,,
CK2022_2 200-1,,0.5258098106292751,0.6214353484436352
AS2011_Ratio H/L Protein RNAi_2,,,
MV2014_Ratio L/H normalized A3___1 (2 min),,,
WZ2023_Su_010_30min,0.3997794118991863,0.5146358746069889,
RN2012_H01,,,0.6001901185655315
KTGR2014_Ratio-Rapa 2 mins,,,
EJN2021_2_Rest_Basal,,,0.6104338562742582
KS2014_Intensity pY_E5_3,,,
MM2018_Ratio H/L replicate 3,,,
EP2017_Pervanadate R#1 normalized log2 ratio,,0.5376511109266687,
HS2024_8_B_T3,0.43608367969608686,0.5353216732648375,
YA2020_Reporter_intensity_Cancer_No.3,,,
KBE2022_Log2_Ex_44_U,,0.5314218360250867,0.6268612039256849
WZ2023_Pe_010_20min,0.3925503192577444,0.5142943901665012,
KS2014_Intensity pY_C6,,,
AS2011_Ratio H/L Normalized_3,,,
RCJD2014_15min_mean,,,
RB2022_3_PreStrength,,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,,
RCJD2014_10min_mean,,,
KS2014_Intensity C1,0.38064843942143656,0.5252719734835417,
FSO2013_Ratio H/M normalized Rep3___1,,,0.5841258582028438
AH2018_SILAC_M_3_C,,,
RKK2015_TNF-α+IKKb/TNF-α,,,
RM2024_Intensity D0-3___2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,,
AH2018_SILAC_M_2_C,,,
AH2018_SILAC_M_2_X,,,
KTGR2014_Ratio-Rapa 15 mins,,,
RM2024_Intensity D4-2___1,,,
KBE2022_Log2_Ex_15_T,,,0.6280804124610078
VOI2024_0.1uM 24 h_1 di,,,
WZ2023_Su_010_10min,0.40053453940390815,0.5128844003848132,
PG2020_Intensity 6h_C,,,0.6315725360163226
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,,
JJ2018_Ratio M/L normalized pP1___1,,,
AH2018_LFQ_M_3_N,,,
VOI2024_0.1uM 24 h_2 mono,,,
AH2018_TMTMS2_3_C,,0.521682690065984,0.575544444100658
CK2022_15 16-1,,,0.6163041164873518
CK2022_3 16-1,,,0.6069674273832372
LY2019_P4-,,,0.57639210843424
FSO2013_Ratio H/L normalized Rep3___2,,,
KS2014_Intensity pY_PV2,,,
HS2024_3_I_N2,,0.5181608747756399,
GF2025_P8_Adh,,,0.6153072802530509
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,,
GF2025_P5_Sph,,,0.5874671117359878
CK2022_10 16-1,,,0.6145723989370354
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,,
VOI2024_0.1uM 2 h_2 di,,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,0.5157590244741281,
NJH2024_Sub2_HIIT_Mid,,,
AMK2021_45I_p3,,,
NJH2024_Sub13_HIIT_Mid,,,
DB2022_LFQ intensity R1.2,,,
DB2022_Intensity R1,,,
NJH2024_Sub12_MICT_Mid,,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,,
UK2020_HCM_4,,,
SAS2015_AZD/DMSO_Exp2,,,
IMM2018_normalised rep. int. CDK5L-1,,0.5220624885690848,
DB2022_LFQ intensity L2.2,,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,,
EP2017_Mitotic R#1 log2 ratio,,0.5273500950649465,
EJN2021_2_Ex_Basal,,,0.6112553807842329
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,,
KTGR2014_Ratio-Rapa 30 mins,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,,
CF2017_FTE 16,,,
AR2021_L41 10 μM,,,0.6170317646870823
CF2017_EOC 2,,,
RB2022_6_PostEndurance,,,
AH2018_SILAC_1_N,,,
NJH2024_Sub10_HIIT_Pre,,,
AS2011_Ratio H/L Inhi_1_2,,,
UK2020_HCM_6,,,
RB2022_7_PreSprint,,,
NJH2024_Sub2_MICT_Pre,,,
HS2024_3_PD_T2,,0.5287063011004802,
CK2022_6 16-1,,,0.6099043011565526
ZX2022_CB treated Replicate 1,,,0.5884469412138039
BS2014_Log2(Ratio H/L normalized Rep_3),,,
TM2022_mock.12h.C,,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,,
HH2022_Reporter intensity 0,0.43851574667226656,,0.6203862146972939
RM2024_Intensity D2-2___2,,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,,
RB2022_1_PreStrength,,,
JJ2018_Ratio H/M normalized pP2___2,,,
AH2018_TMTMS2_2_X,,0.5243802913863632,0.5750728725093509
AR2021_L41 1 μM,,,0.5740194286543386
JJ2018_Ratio H/M normalized pP1___2,,,
AH2018_TMTMS2_1_N,,0.5256473080410901,0.572858583927327
NJH2025_Sub10_MICT_Pre,,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,,
ZX2022_Control Replicate 3,,,0.5902191400337847
KS2014_Intensity C4,0.38389606322235725,0.5287638492412051,0.6053596075643509
AS2011_Ratio H/L Inhi_2,,,
KBE2022_Log2_Ex_18_T,,0.5336527529419027,0.6322667169103819
NJH2025_Sub9_MICT_Pre,,,
RCJD2014_20min_1,,,
MV2014_Ratio H/M normalized B2___1 (5 min),,,
FSO2013_Ratio M/L normalized Rep2___3,,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,,
SR2019_MCF10A_Biol_repl_3,,,
HS2024_7_B_T2,0.4818148353215533,0.5006113662607957,
SAS2015_PLX/DMSO_Exp3,,,
AMK2021_Ctrl_p5,,,
NJH2025_Sub2_HIIT_Mid,,,
AH2018_LFQ_M_3_C,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,,
YA2020_Reporter_intensity_Cancer_No.2,,,
FSO2013_Ratio H/M normalized Rep2___3,,,
RB2022_8_PreSprint,,,
AH2018_SILAC_IT_3_C,,,
WZ2023_Pu_025_10min,0.39368371629366483,0.5132897322185367,
RM2024_Intensity D2-2___3,,,
AS2011_Ratio H/L_1,,,
RCJD2014_10min_3,,,
FSO2013_Ratio M/L normalized Rep3___1,,,0.575189814093641
SR2019_JIMT1_Biol_repl_4,,,
YP2020_Intensity C10_R2_mult_log2,,,
ZCP2016_Ratio H/L Rep 2,,,
CF2017_EOC 4,,,
JJ2018_Ratio H/L normalized pP1___1,,,
WZ2023_Pe_010_30min,0.38766814332685695,0.5133424548311873,
MV2014_Ratio L/M normalized B2___3 (30 min),,,
AH2018_LFQ_IT_3_N,,,
KS2014_Intensity C6,,,
ZQ2022_N3,,,
HW2015_Ratio H/L normalized Exp1,,,
CK2022_12 40-1,,0.5135276467763181,0.6340296320738631
NJH2024_Sub7_MICT_Pre,,,
ZX2022_Control Replicate 1,,,0.5939089541190293
JJ2018_Ratio H/M normalized pP1,,,
CK2022_16 40-1,,0.5109719657252193,0.6339707347263688
AH2018_SILAC_IT_2_C,,,
CK2022_5 40-1,,0.5083667623407894,0.6236892619521724
AH2018_LFQ_3_X,,,
UK2020_UA_3,,,
LY2019_P7-,,,0.5181536901644649
GF2025_P5_Adh,,,0.6030948931211544
RB2022_1_PostStrength,,,
JAW2011_Ratio H/L LS1b,,,
FSO2013_Ratio H/L normalized Rep3___1,,,0.5787622325007741
SR2019_HCC1954_Biol_repl_3,,,
CR2017_Ratio Replicate 2.2,,0.5232293314016153,0.5885816063382419
VOI2024_0.1uM 2 h_1 mono,,,
MV2014_Ratio L/M normalized A2___1 (10 min),,,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,,
CK2022_11 16-1,,,0.6156165516620956
ZQ2022_C1,,,
CR2017_Ratio Replicate 2.1,,0.5224002226386385,0.5759804718101379
PG2020_Intensity CT_B,,,0.6073080821886767
JJ2018_Ratio M/L normalized___2,,,
AH2018_SILAC_MR_1_N,,,
KS2014_Intensity pY_E5_1,,,
JW2021_Before_3,,0.5207890241108911,0.5943270355508168
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,,
MV2014_Ratio M/H normalized B3___3 (30 min),,,
FS2019_db/db1,,,
NJH2025_Sub9_HIIT_Pre,,,
JAW2011_Ratio H/L_1,,,
RCJD2014_20min_3,,,
AH2018_LFQ_3_C,,,
JJ2018_Ratio M/L normalized pP3___2,,,
AMK2021_45I_p1,,,
NJH2025_Sub8_HIIT_Post,,,
AH2018_LFQ_M_3_X,,,
YA2020_Reporter_intensity_Cancer_No.4,,,
KS2014_Intensity pY_E5_2,,,
FSO2013_Ratio H/L normalized Rep1___3,,,
GF2025_P4_Sph,,,0.6060172490413945
RB2022_2_PreEndurance,,,
JW2021_Before_1,,0.5139427446912556,0.5889706941681515
KBE2022_Log2_Ex_25_T,,0.5288347279806976,0.6354891441161313
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,,
MV2014_Ratio L/M normalized A2___2 (10 min),,,
JJ2018_Ratio M/L normalized___1,,,
FR2021_Intensity.H,,,
CK2022_14 16-1,,,0.6167367134758287
AST2020_anti-CD3+PDL2,,,0.5908639884230633
MV2014_Ratio M/L normalized B1___1 (5 min),,,
KBE2022_Log2_Ex_19_T,,0.5246584716887547,0.6367814437086762
KS2014_Intensity pY_N1,,,
RB2022_1_RecoveryEndurance,,,
FSO2013_Ratio H/M normalized Rep1___2,,,
HS2024_8_I_T1,,0.5275482674249851,0.6098718100886821
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,,
EP2017_Mitotic R#2 log2 ratio,,0.5318702464266446,
AH2018_TMTMS2_1_X,,0.52462857490303,0.5740121707347261
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,,
ZCP2016_Ratio H/L Rep 3,,,
AS2011_Ratio H/L Normalized RNAi_1_3,,,
SR2019_MCF10A_Biol_repl_1,,,
NJH2025_Sub8_MICT_Mid,,,
EJN2021_5_Ex_Ins,,,0.606268820666533
HS2024_6_I_N2,,0.5236417013806595,
HH2022_Reporter intensity 4,,,
RBK2021_1326T Late,,,
TM2022_mock.12h.B,,,
NJH2024_Sub12_MICT_Pre,,,
RCJD2014_15min_3,,,
MV2014_Ratio L/H normalized B3___2 (5 min),,,
LG2023_Control-3_intensity,,,
JJ2018_Ratio H/L normalized pP3___2,,,
CF2017_FTE 15,,,
HS2024_4_I_T3,0.42360163971374487,0.5491984925310979,
AH2018_SILAC_1_X,,,
PG2020_Intensity 10h_B,,,0.6531424873069053
AH2018_TMTMS3_1_X,,0.5329865505298803,0.58456821636755
CF2017_FTE 14,,,
NJH2024_Sub13_HIIT_Post,,,
RM2024_Intensity D6-3___3,,,
NJH2025_Sub7_HIIT_Pre,,,
RBK2021_1259T Early,,,
RKK2015_IKK+TNF-α/IKKb,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,,
PG2020_Intensity 6h_A,,,0.6493105234782431
SR2019_HCC1419_Biol_repl_3,,,
KBE2022_Log2_Ex_14_T,,0.5293159064855548,0.6219090377482287
EP2017_Untreated R#2 normalized log2 ratio,,0.5142450771701977,
RM2024_Intensity D0-2___1,,,
DB2022_Intensity L1,,,
LY2019_P5+,,,0.6201629132935615
HS2024_5_I_N2,,0.5331177044983146,
SAS2015_PLX/AZD_Exp3,,,
EP2017_Pervanadate R#2 log2 ratio,,0.5208277597779576,
AS2011_Ratio H/L Normalized RNAi_2_1,,,
